Survival (months) | P | ||
---|---|---|---|
Mean ± SD | Median | ||
Gender | |||
Female | 17.43 ± 9.81 | 16 | 0.476 |
Male | 15.07 ± 9.59 | 11 | |
Cancer type b | |||
Breast | 19.71 ± 6.98 | 21 | |
Hematologic | 29.20 ± 7.59 | 33 | 0.001b |
Lung | 11.79 ± 6.26 | 11 | |
Other | 15.84 ± 11.57 | 11 | |
Pleural effusion | |||
Present | 14.44 ± 8.38 | 11 | 0.420 |
Absent | 17.16 ± 10.65 | 12 | |
Macroscopic appearance of the effusion | |||
Hemorrhagic | 13.85 ± 10.12 | 11 | 0.136 |
Serous | 17.24 ± 9.39 | 15 | |
Nature of the pleural effusion | |||
Malignant | 14.91 ± 10.6 | 9.5 | 0.347 |
Benign | 14.72 ± 6.19 | 12 | |
Radiotherapy | |||
Present | 15.07 ± 8.20 | 12 | 0.701 |
Absent | 17.16 ± 11.77 | 12.5 | |
Distant metastasis | |||
Present | 14.73 ± 7.99 | 11.5 | 0.942 |
Absent | 14.80 ± 8.41 | 12 | |
Nature of the pericardial effusion | |||
Malignant | 11.89 ± 8.78 | 9.5 | 0.004* |
Benign | 18.36 ± 9.58 | 16.5 |